Skip to main content

T. Rowe Price Investment Management, Inc.

Position in NEO — Neogenomics Inc

CIK 1897612 BALTIMORE, MD

Position in NEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,746,663
+$7,176,928 QoQ
Shares Held
1,216,358
+35.3% QoQ
Ownership
0.947%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 266 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $7,246,348,599 across 15 Diagnostics & Research names. NEO ranks #8 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NEO
Neogenomics Inc
This page
1,216,358 $17,746,663

All Filings in NEO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,746,663 1,216,358
2025-12-31 $10,569,735 898,787
2025-09-30 $10,081,849 1,305,939
2025-06-30 $23,839,503 3,261,218
2025-03-31 $31,479,933 3,317,169
2024-12-31 $107,583,269 6,528,111
2024-09-30 $96,485,650 6,541,400
2024-06-30 $93,349,025 6,730,283
2024-03-31 $107,801,173 6,857,581
2023-12-31 $103,269,092 6,382,515
2023-09-30 $67,972,493 5,526,219
2023-06-30 $81,307,547 5,059,586
2023-03-31 $85,334,070 4,901,440
2022-12-31 $26,952,479 2,916,935
2022-09-30 $22,118,306 2,568,909